Smyth Susan S, Coller Barry S, Jackson Rebecca D, Kern Philip A, McIntosh Scott, Meagher Emma A, Rubio Doris M, Sandberg Kathryn, Tsevat Joel, Umans Jason G, Attia Jacqueline, Baker Heather L, Nagel Joan D, McMullen Colleen A, Rosemond Erica
University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Rockefeller University, New York, NY, USA.
J Clin Transl Sci. 2021 Dec 28;6(1):e34. doi: 10.1017/cts.2021.886. eCollection 2022.
Identifying the most effective ways to support career development of early stage investigators in clinical and translational science should yield benefits for the biomedical research community. Institutions with Clinical and Translational Science Awards (CTSA) offer KL2 programs to facilitate career development; however, the sustained impact has not been widely assessed.
A survey comprised of quantitative and qualitative questions was sent to 2144 individuals that had previously received support through CTSA KL2 mechanisms. The 547 responses were analyzed with identifying information redacted.
Respondents held MD (47%), PhD (36%), and MD/PhD (13%) degrees. After KL2 support was completed, physicians' time was divided 50% to research and 30% to patient care, whereas PhD respondents devoted 70% time to research. Funded research effort averaged 60% for the cohort. Respondents were satisfied with their career progression. More than 95% thought their current job was meaningful. Two-thirds felt confident or very confident in their ability to sustain a career in clinical and translational research. Factors cited as contributing to career success included protected time, mentoring, and collaborations.
This first large systematic survey of KL2 alumni provides valuable insight into the group's perceptions of the program and outcome information. Former scholars are largely satisfied with their career choice and direction, national recognition of their expertise, and impact of their work. Importantly, they identified training activities that contributed to success. Our results and future analysis of the survey data should inform the framework for developing platforms to launch sustaining careers of translational scientists.
确定支持临床与转化科学领域早期研究人员职业发展的最有效方法,应为生物医学研究界带来益处。获得临床与转化科学奖(CTSA)的机构提供KL2项目以促进职业发展;然而,其持续影响尚未得到广泛评估。
向2144名曾通过CTSA KL2机制获得支持的个人发送了一份包含定量和定性问题的调查问卷。对547份回复进行了分析,同时隐去了识别信息。
受访者拥有医学博士(MD)学位的占47%,哲学博士(PhD)学位的占36%,医学博士/哲学博士(MD/PhD)学位的占13%。在KL2支持结束后,医生将50%的时间用于研究,30%用于患者护理,而拥有博士学位的受访者将70%的时间用于研究。该队列的资助研究工作平均占60%。受访者对其职业发展感到满意。超过95%的人认为他们目前的工作有意义。三分之二的人对自己在临床和转化研究领域维持职业生涯的能力有信心或非常有信心。被认为有助于职业成功的因素包括受保护的时间、指导和合作。
这项对KL2校友的首次大规模系统性调查,为该群体对项目的看法和成果信息提供了宝贵见解。以前的学者对他们的职业选择和方向、专业知识在全国范围内得到认可以及工作的影响大体上感到满意。重要的是,他们确定了有助于成功的培训活动。我们的结果以及对调查数据的未来分析,应为开发平台以推动转化科学家的可持续职业生涯提供框架参考。